⌘K

Login Start Free

Home/Filings/4/0000905148-25-002732

4//SEC Filing

Levy Adam D. 4

Accession 0000905148-25-002732

CIK 0001781174other

View on SEC.gov Company Profile

Filed

Aug 4, 8:00 PM ET

Accepted

Aug 5, 4:59 PM ET

Size

4.4 KB

Accession

0000905148-25-002732

Insider Transaction Report

Form 4

Period: 2025-08-01

Acrivon Therapeutics, Inc.ACRV

Chief Financial Officer

Transactions

Tax Payment
Common Stock
2025-08-01$1.26/sh−1,164$1,467→ 12,151 total

Footnotes (1)

[F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Documents

1 file

4
form4.xmlPrimary

Issuer

Acrivon Therapeutics, Inc.

CIK 0001781174

Entity typeother

Related Parties

1

filerCIK 0002061876

Filing Metadata

Form type: 4
Filed: Aug 4, 8:00 PM ET
Accepted: Aug 5, 4:59 PM ET
Size: 4.4 KB

View on SEC.gov